Comparing Healthcare Resource Utilization and Costs for Patients with Normal Tension Glaucoma Across Levels of Severity: A Retrospective Cohort Study

Brennan Beal,1 Vanessa Shih,2 Joanna Campbell,2 David Veenstra,1 Beth Devine1 1The Comparative Health Outcomes, Policy and Economics (CHOICE) Institute, University of Washington, Seattle, WA, USA; 2Healthcare Economics and Outcomes Research, AbbVie, Chicago, IL, USACorrespondence: Brennan BealThe Co...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Beal B, Shih V, Campbell J, Veenstra D, Devine B
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	healthcare resource utilization normal tension glaucoma low tension glaucoma healthcare costs Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/7feb769b28a74b74aeea537c9158cbea
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:7feb769b28a74b74aeea537c9158cbea
record_format	dspace
spelling	oai:doaj.org-article:7feb769b28a74b74aeea537c9158cbea2021-12-02T14:24:10ZComparing Healthcare Resource Utilization and Costs for Patients with Normal Tension Glaucoma Across Levels of Severity: A Retrospective Cohort Study1177-5483https://doaj.org/article/7feb769b28a74b74aeea537c9158cbea2021-02-01T00:00:00Zhttps://www.dovepress.com/comparing-healthcare-resource-utilization-and-costs-for-patients-with--peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Brennan Beal,1 Vanessa Shih,2 Joanna Campbell,2 David Veenstra,1 Beth Devine1 1The Comparative Health Outcomes, Policy and Economics (CHOICE) Institute, University of Washington, Seattle, WA, USA; 2Healthcare Economics and Outcomes Research, AbbVie, Chicago, IL, USACorrespondence: Brennan BealThe Comparative Health Outcomes, Policy and Economics (CHOICE) Institute, University of Washington, Suite H-375, Box 35760, 1959 NE Pacific Street, Seattle, WA, 98195-7630, USATel +1 704 742 0288Fax +1 206-543-3835Email brennanbeal@gmail.comPurpose: To estimate the healthcare resource utilization (HCRU) and costs for patients with normal tension glaucoma (NTG) as well as their payers across various levels of disease severity.Patients and Methods: Our study was a retrospective cohort study of 6330 US NTG patients. Patients were enrolled if they were 40 years or older and had two or more qualifying NTG diagnoses within the enrollment period, October 1st, 2015 to December 31st, 2017. Our analysis was carried out for two cohorts – those with unilateral disease and those with bilateral disease. Baseline demographic and clinical characteristics were assessed for a 12-month pre-index period. The follow up period was 12-months post-index. We employed generalized linear models to model HCRU and costs.Results: Patients with severe, bilateral disease, filled more than two additional prescriptions annually (2.5, p< 0.001, 95% CI [2.0, 3.1]) when compared to their mild counterparts and accounted for 111 (p< 0.001, 95% CI [83.5, 139.1]) extra days of supply of glaucoma medications. These patients face an adjusted $187 (p< 0.001, 95% CI [145, 229]) more out-of-pocket (OOP), and payers an additional $598 (p< 0.001, 95% CI [$370, $826]), than their counterparts with a mild diagnosis on an annual basis. Total annual payer costs, on average (SD) for those with severe bilateral NTG were $1175 ($2222).Conclusion: Our results suggest that patient and payer burden is significantly greater for those with severe disease compared to those with mild NTG. The excess burden is attributed to additional HCRU and the associated financial burden. Payers experienced a much larger financial burden from patients with severe disease compared to those with mild NTG. Approximately half of the cost differences can be attributed to additional prescription use.Keywords: healthcare resource utilization, normal tension glaucoma, low tension glaucoma, healthcare costsBeal BShih VCampbell JVeenstra DDevine BDove Medical Pressarticlehealthcare resource utilizationnormal tension glaucomalow tension glaucomahealthcare costsOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 15, Pp 453-460 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	healthcare resource utilization normal tension glaucoma low tension glaucoma healthcare costs Ophthalmology RE1-994
spellingShingle	healthcare resource utilization normal tension glaucoma low tension glaucoma healthcare costs Ophthalmology RE1-994 Beal B Shih V Campbell J Veenstra D Devine B Comparing Healthcare Resource Utilization and Costs for Patients with Normal Tension Glaucoma Across Levels of Severity: A Retrospective Cohort Study
description	Brennan Beal,1 Vanessa Shih,2 Joanna Campbell,2 David Veenstra,1 Beth Devine1 1The Comparative Health Outcomes, Policy and Economics (CHOICE) Institute, University of Washington, Seattle, WA, USA; 2Healthcare Economics and Outcomes Research, AbbVie, Chicago, IL, USACorrespondence: Brennan BealThe Comparative Health Outcomes, Policy and Economics (CHOICE) Institute, University of Washington, Suite H-375, Box 35760, 1959 NE Pacific Street, Seattle, WA, 98195-7630, USATel +1 704 742 0288Fax +1 206-543-3835Email brennanbeal@gmail.comPurpose: To estimate the healthcare resource utilization (HCRU) and costs for patients with normal tension glaucoma (NTG) as well as their payers across various levels of disease severity.Patients and Methods: Our study was a retrospective cohort study of 6330 US NTG patients. Patients were enrolled if they were 40 years or older and had two or more qualifying NTG diagnoses within the enrollment period, October 1st, 2015 to December 31st, 2017. Our analysis was carried out for two cohorts – those with unilateral disease and those with bilateral disease. Baseline demographic and clinical characteristics were assessed for a 12-month pre-index period. The follow up period was 12-months post-index. We employed generalized linear models to model HCRU and costs.Results: Patients with severe, bilateral disease, filled more than two additional prescriptions annually (2.5, p< 0.001, 95% CI [2.0, 3.1]) when compared to their mild counterparts and accounted for 111 (p< 0.001, 95% CI [83.5, 139.1]) extra days of supply of glaucoma medications. These patients face an adjusted $187 (p< 0.001, 95% CI [145, 229]) more out-of-pocket (OOP), and payers an additional $598 (p< 0.001, 95% CI [$370, $826]), than their counterparts with a mild diagnosis on an annual basis. Total annual payer costs, on average (SD) for those with severe bilateral NTG were $1175 ($2222).Conclusion: Our results suggest that patient and payer burden is significantly greater for those with severe disease compared to those with mild NTG. The excess burden is attributed to additional HCRU and the associated financial burden. Payers experienced a much larger financial burden from patients with severe disease compared to those with mild NTG. Approximately half of the cost differences can be attributed to additional prescription use.Keywords: healthcare resource utilization, normal tension glaucoma, low tension glaucoma, healthcare costs
format	article
author	Beal B Shih V Campbell J Veenstra D Devine B
author_facet	Beal B Shih V Campbell J Veenstra D Devine B
author_sort	Beal B
title	Comparing Healthcare Resource Utilization and Costs for Patients with Normal Tension Glaucoma Across Levels of Severity: A Retrospective Cohort Study
title_short	Comparing Healthcare Resource Utilization and Costs for Patients with Normal Tension Glaucoma Across Levels of Severity: A Retrospective Cohort Study
title_full	Comparing Healthcare Resource Utilization and Costs for Patients with Normal Tension Glaucoma Across Levels of Severity: A Retrospective Cohort Study
title_fullStr	Comparing Healthcare Resource Utilization and Costs for Patients with Normal Tension Glaucoma Across Levels of Severity: A Retrospective Cohort Study
title_full_unstemmed	Comparing Healthcare Resource Utilization and Costs for Patients with Normal Tension Glaucoma Across Levels of Severity: A Retrospective Cohort Study
title_sort	comparing healthcare resource utilization and costs for patients with normal tension glaucoma across levels of severity: a retrospective cohort study
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/7feb769b28a74b74aeea537c9158cbea
work_keys_str_mv	AT bealb comparinghealthcareresourceutilizationandcostsforpatientswithnormaltensionglaucomaacrosslevelsofseverityaretrospectivecohortstudy AT shihv comparinghealthcareresourceutilizationandcostsforpatientswithnormaltensionglaucomaacrosslevelsofseverityaretrospectivecohortstudy AT campbellj comparinghealthcareresourceutilizationandcostsforpatientswithnormaltensionglaucomaacrosslevelsofseverityaretrospectivecohortstudy AT veenstrad comparinghealthcareresourceutilizationandcostsforpatientswithnormaltensionglaucomaacrosslevelsofseverityaretrospectivecohortstudy AT devineb comparinghealthcareresourceutilizationandcostsforpatientswithnormaltensionglaucomaacrosslevelsofseverityaretrospectivecohortstudy
_version_	1718391435633360896

Comparing Healthcare Resource Utilization and Costs for Patients with Normal Tension Glaucoma Across Levels of Severity: A Retrospective Cohort Study

Ejemplares similares